<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[bms Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/bms.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to bms]]></description>
	<s:counts start="0" returned="20" found="28" />
	<language>en-us</language>
	<item>
		<title><![CDATA[BMS Is Losing Suits in Plavix-Apotex Fiasco; Another $125M Down the Toilet]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10003329/bms-is-losing-suits-in-plavix-apotex-fiasco-another-125m-down-the-toilet/]]></link>
		<description><![CDATA[Bristol-Myers Squibb is mostly losing its Plavix securities litigation. It's 10-Q filing with the SEC says it just paid out $125 million to settle a suit over the 2006 fiasco; it settled a second suit for an undisclosed sum; and two others remain pending. by Jim Edwards]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 28 Jul 2009 08:33:58 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fiasco.html"><![CDATA[Fiasco]]></category>
		<category domain="http://resources.bnet.com/topic/suit.html"><![CDATA[Suit]]></category>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[BMS's Bodnar Caught in His Own Lies on Apotex-Plavix Deal]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001614/bmss-bodnar-caught-in-his-own-lies-on-apotex-plavix-deal/]]></link>
		<description><![CDATA[Former Bristol-Myers Squibb svp/strategy Andrew Bodnar faces a year in prison after he pled guilty to lying to the FTC about BMS's generic deal with Apotex.    The conviction carries a lesson for senior drug company executives hoping to put one over on the government: If you're going...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 07 Apr 2009 12:11:38 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/generic.html"><![CDATA[Generic]]></category>
		<category domain="http://resources.bnet.com/topic/agreement.html"><![CDATA[Agreement]]></category>
		<category domain="http://resources.bnet.com/topic/ftc.html"><![CDATA[FTC]]></category>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/apotex.html"><![CDATA[Apotex]]></category>
		<category domain="http://resources.bnet.com/topic/plavix.html"><![CDATA[Plavix]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[BMS Settles Plavix Allegations for Pennies; Ex-CEO Dolan Vindicated (Slightly)]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001499/bms-settles-plavix-allegations-for-pennies-ex-ceo-dolan-vindicated-slightly/]]></link>
		<description><![CDATA[Bristol-Myers Squibb will pay $2.1 million to settle FTC allegations it made false statements regarding its deal over bloodthinner Plavix with Apotex, according to the WSJ.    The news means that BMS has settled all its regulatory troubles over Plavix with the FTC and the states for a...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 27 Mar 2009 08:44:53 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[Patent]]></category>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/plavix.html"><![CDATA[Plavix]]></category>
		<category domain="http://resources.bnet.com/topic/ex-ceo+dolan.html"><![CDATA[Ex-CEO Dolan]]></category>
		<category domain="http://resources.bnet.com/topic/apotex.html"><![CDATA[Apotex]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[BMS Execs Get Cash Not to Ride Private Jets; 61% Pay Raise to $59 Million]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001450/bms-execs-get-cash-not-to-ride-private-jets-plus-61-pay-raise-to-59-million/]]></link>
		<description><![CDATA[Bristol-Myers Squibb employees: Have you ever been made late by a meeting that ran a bit too long? If so, the company will provide you with a private jet to get you to your next appointment on time.    At least, that was the perk given to R&D...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 24 Mar 2009 08:32:16 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[Security]]></category>
		<category domain="http://resources.bnet.com/topic/aircraft.html"><![CDATA[Aircraft]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/company+aircraft.html"><![CDATA[Company Aircraft]]></category>
		<category domain="http://resources.bnet.com/topic/aerospace+%2526+defense.html"><![CDATA[Aerospace & Defense]]></category>
		<category domain="http://resources.bnet.com/topic/taxes.html"><![CDATA[Taxes]]></category>
		<category domain="http://resources.bnet.com/topic/free+trade.html"><![CDATA[Free Trade]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/financial+planning.html"><![CDATA[Financial Planning]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="tickers">BMY</category>
	</item>
	<item>
		<title><![CDATA[The Sanofi-Bristol-Myers Squibb Worst-Case Scenario]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000809/the-sanofi-bristol-myers-squibb-worst-case-scenario/]]></link>
		<description><![CDATA[Bristol-Myers Squibb seems to live permanently with the rumor that it is about to be acquired by Sanofi-Aventis. The last time this old saw popped up was in the fall of 2008. At that time BNET said "Perhaps itâ€™s time to consummate this relationship."    This time around,...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 03 Feb 2009 08:01:28 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/plavix.html"><![CDATA[Plavix]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi.html"><![CDATA[Sanofi]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/asset+management.html"><![CDATA[Asset Management]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/operational+planning.html"><![CDATA[Operational Planning]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[BMS Wins Ruling That Could Crimp India's Thriving Generics Business]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000600/bms-wins-ruling-that-could-crimp-indias-thriving-generics-business/]]></link>
		<description><![CDATA[Bristol-Myers Squibbb just won a ruling in an Indian court that could put generic makers there on the defensive. For years, the Indian drug business has grown primarily from making generics. Companies like Dr. Reddy's, Ranbaxy, Cilpa and Hetero Drugs have chosen to copy compounds marketed in the West rather...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 16 Jan 2009 03:16:35 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/india.html"><![CDATA[India]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[Patent]]></category>
		<category domain="http://resources.bnet.com/topic/approval.html"><![CDATA[Approval]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/livemint.html"><![CDATA[LiveMint]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[BMS Braces for Tell-All Book by Abilify Whistleblower]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000541/bms-braces-for-tell-all-book-by-abilify-whistleblower/]]></link>
		<description><![CDATA[In January, Andy Behrman's non-disclosure agreement with Bristol-Myers Squibb expires. This will leave Behrman free to market his new book, Adventures in the Drug Trade: I Was a Big Pharma Pusher. Behrman is best known as the author of Electroboy, the 2002 account of his years spent trying to treat...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 29 Dec 2008 09:00:53 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/movie.html"><![CDATA[Movie]]></category>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/andy+behrman.html"><![CDATA[Andy Behrman]]></category>
		<category domain="http://resources.bnet.com/topic/olsen.html"><![CDATA[Olsen]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Why a Pfizer Takeover of Bristol-Myers Squibb Seems Unlikely]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000443/why-a-pfizer-takeover-of-bristol-myers-squibb-seems-unlikely/]]></link>
		<description><![CDATA[Deutsche Bank analyst Barbara Ryan left pharma pholks with an interesting wishbone to chew on prior to Thanksgiving -- the notion that large pharma was overdue for consolidation and that Pfizer ought to consider finally merging with Bristol-Myers Squibb. It's not a new idea, of course. But is a Pfizer...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Sat, 29 Nov 2008 10:10:07 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/kindler.html"><![CDATA[Kindler]]></category>
		<category domain="http://resources.bnet.com/topic/mergers+%2526+acquisitions.html"><![CDATA[Mergers & Acquisitions]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+law.html"><![CDATA[Corporate Law]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">BMY,PFE</category>
	</item>
	<item>
		<title><![CDATA[Bristol-Myers Squibb Plans $2.5 Bil. in Layoffs, Cuts]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000386/bristol-myers-squibb-plans-25-bil-in-layoffs-cuts/]]></link>
		<description><![CDATA[Bristol-Myers Squibb made a presentation this morning at the Credit Suisse Healthcare Conference that showed CFO John Marc-Huet wants to save the company $2.5 billion in "productivity initiatives." He's going to squeeze these out of "headcount and related costs" -- which sounds like a euphemism for layoffs.   ...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 13 Nov 2008 12:47:18 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/layoff.html"><![CDATA[Layoff]]></category>
		<category domain="http://resources.bnet.com/topic/foreign-exchange.html"><![CDATA[Foreign-exchange]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/john+marc-huet.html"><![CDATA[John Marc-Huet]]></category>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/currency+%2526+foreign+exchange.html"><![CDATA[Currency & Foreign Exchange]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="tickers">BMY</category>
	</item>
	<item>
		<title><![CDATA[Should Sanofi-Aventis Buy Bristol Myers-Squibb?]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000341/should-sanofi-aventis-buy-bristol-myers-squibb/]]></link>
		<description><![CDATA[Bristol-Myers Squibb CEO James Cornelius said in a recent earnings call that due to its healthy cash position it may be on the prowl for biotech acquisitions. That's ironic because it is looking more like BMS itself could be the company to be acquired, possibly by Sanofi-Aventis.   ...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 27 Oct 2008 12:37:30 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/sanofi-aventis.html"><![CDATA[Sanofi-Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/ceo.html"><![CDATA[CEO]]></category>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi.html"><![CDATA[Sanofi]]></category>
		<category domain="http://resources.bnet.com/topic/mergers+%2526+acquisitions.html"><![CDATA[Mergers & Acquisitions]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+law.html"><![CDATA[Corporate Law]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi-aventis.html"><![CDATA[Sanofi-Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/ceo.html"><![CDATA[CEO]]></category>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi.html"><![CDATA[Sanofi]]></category>
		<category domain="http://resources.bnet.com/topic/mergers+%2526+acquisitions.html"><![CDATA[Mergers & Acquisitions]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+law.html"><![CDATA[Corporate Law]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[The Lilly-ImClone Deal Worst-Case Scenario]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000255/the-lilly-imclone-deal-worst-case-scenario/]]></link>
		<description><![CDATA[Some people were apparently surprised that Eli Lilly has emerged as the mystery $70-a-share bidder for ImClone. BNET readers weren't among them, as I noted a few days ago this is just the kind of bold plan that CEO John Lechleiter seems to favor.    Interestingly, ImClone's stock...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 02 Oct 2008 09:57:44 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/asset.html"><![CDATA[Asset]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/imclone.html"><![CDATA[ImClone]]></category>
		<category domain="http://resources.bnet.com/topic/lilly.html"><![CDATA[Lilly]]></category>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/asset+management.html"><![CDATA[Asset Management]]></category>
		<category domain="http://resources.bnet.com/topic/operational+planning.html"><![CDATA[Operational Planning]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="tickers">BMY</category>
	</item>
	<item>
		<title><![CDATA[Ex-Bristol-Myers Squibb official indicted for lying to feds]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200804/ai_n25345178]]></link>
		<description><![CDATA[WASHINGTON AFP &#8212; A former senior vice president of Bristol-Myers Squibb Company BMS has been indicted for lying about a patent deal involving the blood-thinning drug Plavix, justice officials said Wednesday.  Andrew Bodnar faces up to five years in prison and a fine of more than 250,000 dollars if...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 23 Apr 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/ftc.html"><![CDATA[FTC]]></category>
		<category domain="http://resources.bnet.com/topic/litigation.html"><![CDATA[Litigation]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/settlement.html"><![CDATA[settlement]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+department+of+justice.html"><![CDATA[U.S. Department of Justice]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="tickers">BMY</category>
	</item>
	<item>
		<title><![CDATA[Otsuka to Pay More Than $4 Million to Resolve Off-Label Marketing Allegations Involving Abilify]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5554/is_200803/ai_n25311457]]></link>
		<description><![CDATA[To: NATIONAL EDITORS Contact: U.S. Department of Justice Office of Public Affairs, +1- 202-514-2007, TDD +1-202-514-1888  WASHINGTON, March 27 /PRNewswire-USNewswire/ -- Otsuka American Pharmaceutical Inc., the U.S. subsidiary of Japanese pharmaceutical manufacturer Otsuka Pharmaceutical Co., Ltd., has agreed to pay more than $4 million to resolve allegations that it...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 27 Mar 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/litigation.html"><![CDATA[Litigation]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[SALES]]></category>
		<category domain="http://resources.bnet.com/topic/settlement.html"><![CDATA[settlement]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+department+of+justice.html"><![CDATA[U.S. Department of Justice]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Frost & Sullivan Recognizes MIV Therapeutics for Technological Breakthroughs in Interventional Cardiology Enabled by Its HAp-based Drug Delivery Systems]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_March_13/ai_n24921249]]></link>
		<description><![CDATA[PALO ALTO, Calif. -- Based on its recent analysis of the interventional cardiology markets, Frost & Sullivan recognizes MIV Therapeutics, Inc. (OTCBB:MIVT) (Frankfurt:MIV), a leading developer of next-generation coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, with the 2008 North American Frost & Sullivan...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 13 Mar 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/frost+%2526+sullivan.html"><![CDATA[Frost & Sullivan]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/polymer.html"><![CDATA[polymer]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[More supplier consolidation as OEMs strive for lighter, quieter, odour-free cars: technical trends in automotive are challenging ingenuity in the urethanes world--as the supplier and automaker sectors struggle with their commercial viability.(automotive)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6471/is_200710/ai_n25767298]]></link>
		<description><![CDATA[Vehicle makers are having to reinvent car engineering in areas such  as cutting weight, using greener technology and lowering emissions.    But, particularly in the US, these demands come at a time when the  automakers are struggling. Their total market is diminishing and the  transplants...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 01 Oct 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/car.html"><![CDATA[car]]></category>
		<category domain="http://resources.bnet.com/topic/consolidation.html"><![CDATA[consolidation]]></category>
		<category domain="http://resources.bnet.com/topic/emission.html"><![CDATA[emission]]></category>
		<category domain="http://resources.bnet.com/topic/general+motors+corp..html"><![CDATA[General Motors Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/iac%252finteractive+corp..html"><![CDATA[IAC/InterActive Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/lear+corp..html"><![CDATA[Lear Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[MARKETING]]></category>
		<category domain="http://resources.bnet.com/topic/oem.html"><![CDATA[OEM]]></category>
		<category domain="http://resources.bnet.com/topic/supplier.html"><![CDATA[supplier]]></category>
		<category domain="http://resources.bnet.com/topic/technology.html"><![CDATA[technology]]></category>
		<category domain="http://resources.bnet.com/topic/the+dow+chemical+co..html"><![CDATA[The Dow Chemical Co.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GMGMQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IACI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LEA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DOW</category>
		<category domain="tickers">GMGMQ,IACI,LEA,DOW</category>
	</item>
	<item>
		<title><![CDATA[Bristol-Myers Squibb Pleads Guilty to Lying to the Federal Government About Deal Involving Blood-Thinning Drug]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5554/is_200705/ai_n21898872]]></link>
		<description><![CDATA[To: AND HEALTH/MEDICAL EDITORSContact: U.S. Department of Justice, +1-202-514-2007, http:// www.usdoj.gov WASHINGTON, May 30 /PRNewswire-USNewsire/ -- The Department of Justice announced today that Bristol-Myers Squibb Company BMS has agreed to plead guilty and pay a $1 million criminal fine for lying to the federal government about a patent deal involving...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 30 May 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/ftc.html"><![CDATA[FTC]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/litigation.html"><![CDATA[Litigation]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+department+of+justice.html"><![CDATA[U.S. Department of Justice]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="tickers">BMY</category>
	</item>
	<item>
		<title><![CDATA[Daily Market Alert for Bristol-Myers Squibb Co.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200702/ai_n19689290]]></link>
		<description><![CDATA[M2 PRESSWIRE-13 February 2007-Biotech News: Daily Market Alert for  Bristol-Myers Squibb Co.C1994-2007 M2 COMMUNICATIONS LTD    RDATE:13022007    Do you have high cholesterol? If so, you're a potential  customer for Bristol-Myers Squibb BMS. The pharmaceutical giant makes  platelet inhibitor Plavix and cholesterol reduction...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 13 Feb 2007 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/cholesterol.html"><![CDATA[cholesterol]]></category>
		<category domain="http://resources.bnet.com/topic/countrywide+financial+corp..html"><![CDATA[Countrywide Financial Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CFC</category>
		<category domain="tickers">BMY,CFC</category>
	</item>
	<item>
		<title><![CDATA[The Digica - BMS strategic offering for JD Edwards customers.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200607/ai_n20172845]]></link>
		<description><![CDATA[M2 PRESSWIRE-27 July 2006-DIGICA: The Digica - BMS strategic  offering for JD Edwards customersC1994-2006 M2 COMMUNICATIONS LTD    RDATE:27072006    Digica and BMS Beoley Mill Software Ltd announce their strategic  partnership to provide an end-to-end outsourced IT service capability  for JD Edwards World...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 27 Jul 2006 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/digica.html"><![CDATA[Digica]]></category>
		<category domain="http://resources.bnet.com/topic/j.d.+edwards+%2526+co..html"><![CDATA[J.D. Edwards & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[US pharma giant gives up AIDS drug patent in Thailand]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200401/ai_kepm353103]]></link>
		<description><![CDATA[BANGKOK AFP ? A US pharmaceutical firm has given up its patent in Thailand to produce a generic AIDS drug in a historic move that could see drug costs plunge, activists said.  Bristol-Myers Squibb BMS reached agreement Friday to return its patent to produce the anti-retroviral drug didanosine ddi...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sat, 17 Jan 2004 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/ddi.html"><![CDATA[Ddi]]></category>
		<category domain="http://resources.bnet.com/topic/hardware.html"><![CDATA[HARDWARE]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/tablets.html"><![CDATA[Tablets]]></category>
		<category domain="http://resources.bnet.com/topic/thailand.html"><![CDATA[Thailand]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Technology Transfer: NIH-Private Sector Partnership in the Development of Taxol. ]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_go2753/is_200307/ai_n9125060]]></link>
		<description><![CDATA[GAO-03-829 June 4, 2003   The transfer of technology from government-funded medical research laboratories to the private sector aims to have new pharmaceuticals brought to market more efficiently than would be possible for a federal agency acting alone. Much of the pharmaceutical-related technology transfer originates with research funded by...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 01 Jul 2003 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/bms.html"><![CDATA[BMS]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/financial.html"><![CDATA[financial]]></category>
		<category domain="http://resources.bnet.com/topic/general+accounting+office.html"><![CDATA[General Accounting Office]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/technology.html"><![CDATA[technology]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
